Flagship explainer
What drives Kiniksa Pharmaceuticals International, plc’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $59M | FY2025 |
| |
| Income before tax | $88.9M | FY2025 |
|
| Operating income | $77.2M | FY2025 |
|
| $678M | FY2025 |
| |
| Ending assets | $764M | FY2025 |
|
| Beginning assets | $581M | FY2024 |
|
| $568M | FY2025 |
| |
| $438M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001104659-26-019168